1. Home
  2. Protocols and Guidelines
  3. Upcoming CAP Guidelines
  4. Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies

Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies

Background

The process for the detection of monoclonal gammopathies (MGs) is highly complex. To obtain an accurate diagnosis, diagnostic data must be compiled from several areas of the laboratory (eg, total protein, immunoglobulin levels, gel or capillary electrophoreses patterns).

Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies,” establishes recommendations that pathologists and clinicians can implement to better manage testing and improve the accurate diagnoses of patients with monoclonal gammopathies (MGs).

Guideline Information

  • Guideline Status: Active
  • Published online ahead of print: August 4, 2021

Guideline Tools & Resources

The following tools and resources are available to help implement the guideline:

Collaborators

American Association for Clinical Chemistry

American Society for Clinical Pathology

American Society of Hematology

International Myeloma Working Group

Review more upcoming CAP evidence-based guidelines by the Center.

Have a Question or Comment?

Send us an email.

Email the Center Right Arrow